nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—Alzheimer's disease	0.578	1	CbGaD
Arsenic trioxide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0322	0.432	CbGbCtD
Arsenic trioxide—CYP3A4—Donepezil—Alzheimer's disease	0.0257	0.345	CbGbCtD
Arsenic trioxide—CYP3A4—Galantamine—Alzheimer's disease	0.0166	0.223	CbGbCtD
Arsenic trioxide—CCND1—blood vessel—Alzheimer's disease	0.00527	0.0569	CbGeAlD
Arsenic trioxide—MAPK3—blood vessel—Alzheimer's disease	0.00393	0.0424	CbGeAlD
Arsenic trioxide—AKT1—blood vessel—Alzheimer's disease	0.0037	0.04	CbGeAlD
Arsenic trioxide—JUN—blood vessel—Alzheimer's disease	0.00322	0.0348	CbGeAlD
Arsenic trioxide—CCND1—embryo—Alzheimer's disease	0.00314	0.0339	CbGeAlD
Arsenic trioxide—CCND1—forebrain—Alzheimer's disease	0.00278	0.03	CbGeAlD
Arsenic trioxide—MAPK1—embryo—Alzheimer's disease	0.00265	0.0286	CbGeAlD
Arsenic trioxide—CCND1—telencephalon—Alzheimer's disease	0.00255	0.0276	CbGeAlD
Arsenic trioxide—MAPK3—embryo—Alzheimer's disease	0.00234	0.0253	CbGeAlD
Arsenic trioxide—MAPK1—forebrain—Alzheimer's disease	0.00234	0.0253	CbGeAlD
Arsenic trioxide—AKT1—embryo—Alzheimer's disease	0.00221	0.0239	CbGeAlD
Arsenic trioxide—TXNRD1—forebrain—Alzheimer's disease	0.00218	0.0235	CbGeAlD
Arsenic trioxide—MAPK1—telencephalon—Alzheimer's disease	0.00215	0.0233	CbGeAlD
Arsenic trioxide—MAPK3—forebrain—Alzheimer's disease	0.00207	0.0224	CbGeAlD
Arsenic trioxide—TXNRD1—telencephalon—Alzheimer's disease	0.002	0.0216	CbGeAlD
Arsenic trioxide—AKT1—forebrain—Alzheimer's disease	0.00195	0.0211	CbGeAlD
Arsenic trioxide—JUN—embryo—Alzheimer's disease	0.00192	0.0208	CbGeAlD
Arsenic trioxide—IKBKB—embryo—Alzheimer's disease	0.00191	0.0207	CbGeAlD
Arsenic trioxide—MAPK3—telencephalon—Alzheimer's disease	0.0019	0.0206	CbGeAlD
Arsenic trioxide—AKT1—telencephalon—Alzheimer's disease	0.0018	0.0194	CbGeAlD
Arsenic trioxide—JUN—forebrain—Alzheimer's disease	0.0017	0.0184	CbGeAlD
Arsenic trioxide—JUN—telencephalon—Alzheimer's disease	0.00156	0.0169	CbGeAlD
Arsenic trioxide—IKBKB—telencephalon—Alzheimer's disease	0.00156	0.0168	CbGeAlD
Arsenic trioxide—CCND1—nervous system—Alzheimer's disease	0.00151	0.0163	CbGeAlD
Arsenic trioxide—CCND1—central nervous system—Alzheimer's disease	0.00145	0.0157	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—Alzheimer's disease	0.00142	0.0153	CbGeAlD
Arsenic trioxide—MAPK1—nervous system—Alzheimer's disease	0.00127	0.0137	CbGeAlD
Arsenic trioxide—MAPK1—central nervous system—Alzheimer's disease	0.00122	0.0132	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—Alzheimer's disease	0.0012	0.0129	CbGeAlD
Arsenic trioxide—TXNRD1—nervous system—Alzheimer's disease	0.00118	0.0128	CbGeAlD
Arsenic trioxide—CCND1—brain—Alzheimer's disease	0.00115	0.0125	CbGeAlD
Arsenic trioxide—TXNRD1—central nervous system—Alzheimer's disease	0.00114	0.0123	CbGeAlD
Arsenic trioxide—MAPK3—nervous system—Alzheimer's disease	0.00112	0.0122	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—Alzheimer's disease	0.00111	0.012	CbGeAlD
Arsenic trioxide—MAPK3—central nervous system—Alzheimer's disease	0.00108	0.0117	CbGeAlD
Arsenic trioxide—AKT1—nervous system—Alzheimer's disease	0.00106	0.0115	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—Alzheimer's disease	0.00106	0.0114	CbGeAlD
Arsenic trioxide—AKT1—central nervous system—Alzheimer's disease	0.00102	0.011	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—Alzheimer's disease	0.000998	0.0108	CbGeAlD
Arsenic trioxide—MAPK1—brain—Alzheimer's disease	0.000971	0.0105	CbGeAlD
Arsenic trioxide—JUN—nervous system—Alzheimer's disease	0.000923	0.00997	CbGeAlD
Arsenic trioxide—IKBKB—nervous system—Alzheimer's disease	0.000919	0.00993	CbGeAlD
Arsenic trioxide—TXNRD1—brain—Alzheimer's disease	0.000904	0.00977	CbGeAlD
Arsenic trioxide—JUN—central nervous system—Alzheimer's disease	0.000889	0.0096	CbGeAlD
Arsenic trioxide—IKBKB—central nervous system—Alzheimer's disease	0.000885	0.00956	CbGeAlD
Arsenic trioxide—JUN—cerebellum—Alzheimer's disease	0.000869	0.00939	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—Alzheimer's disease	0.000865	0.00934	CbGeAlD
Arsenic trioxide—MAPK3—brain—Alzheimer's disease	0.00086	0.00929	CbGeAlD
Arsenic trioxide—CYP1B1—telencephalon—Alzheimer's disease	0.000834	0.00901	CbGeAlD
Arsenic trioxide—AKT1—brain—Alzheimer's disease	0.000811	0.00876	CbGeAlD
Arsenic trioxide—JUN—brain—Alzheimer's disease	0.000706	0.00762	CbGeAlD
Arsenic trioxide—IKBKB—brain—Alzheimer's disease	0.000702	0.00759	CbGeAlD
Arsenic trioxide—ABCB1—blood vessel—Alzheimer's disease	0.000631	0.00682	CbGeAlD
Arsenic trioxide—CYP1B1—nervous system—Alzheimer's disease	0.000492	0.00532	CbGeAlD
Arsenic trioxide—CYP1B1—central nervous system—Alzheimer's disease	0.000474	0.00512	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—Alzheimer's disease	0.000463	0.005	CbGeAlD
Arsenic trioxide—ABCB1—embryo—Alzheimer's disease	0.000376	0.00407	CbGeAlD
Arsenic trioxide—CYP1B1—brain—Alzheimer's disease	0.000376	0.00406	CbGeAlD
Arsenic trioxide—CYP1A1—nervous system—Alzheimer's disease	0.000348	0.00376	CbGeAlD
Arsenic trioxide—CYP1A1—central nervous system—Alzheimer's disease	0.000335	0.00362	CbGeAlD
Arsenic trioxide—ABCB1—forebrain—Alzheimer's disease	0.000333	0.0036	CbGeAlD
Arsenic trioxide—ABCB1—telencephalon—Alzheimer's disease	0.000306	0.00331	CbGeAlD
Arsenic trioxide—CYP1A1—brain—Alzheimer's disease	0.000266	0.00287	CbGeAlD
Arsenic trioxide—CYP3A4—nervous system—Alzheimer's disease	0.000255	0.00276	CbGeAlD
Arsenic trioxide—CYP3A4—central nervous system—Alzheimer's disease	0.000246	0.00266	CbGeAlD
Arsenic trioxide—ABCB1—nervous system—Alzheimer's disease	0.000181	0.00195	CbGeAlD
Arsenic trioxide—ABCB1—central nervous system—Alzheimer's disease	0.000174	0.00188	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—Alzheimer's disease	0.00017	0.00184	CbGeAlD
Arsenic trioxide—ABCB1—brain—Alzheimer's disease	0.000138	0.00149	CbGeAlD
Arsenic trioxide—AKT1—Signaling Pathways—HTR2A—Alzheimer's disease	3.8e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	3.79e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—A2M—Alzheimer's disease	3.79e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.79e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PRKCG—Alzheimer's disease	3.78e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS3—Alzheimer's disease	3.78e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—Alzheimer's disease	3.77e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCR5—Alzheimer's disease	3.77e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LPL—Alzheimer's disease	3.72e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—Alzheimer's disease	3.7e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CALM1—Alzheimer's disease	3.69e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MEF2C—Alzheimer's disease	3.69e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HTR2A—Alzheimer's disease	3.69e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NGF—Alzheimer's disease	3.68e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PPARG—Alzheimer's disease	3.68e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEP—Alzheimer's disease	3.68e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—APOE—Alzheimer's disease	3.68e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS3—Alzheimer's disease	3.67e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—Alzheimer's disease	3.66e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—Alzheimer's disease	3.65e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CAV1—Alzheimer's disease	3.64e-06	1.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—BCL2—Alzheimer's disease	3.64e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—Alzheimer's disease	3.63e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PRKCG—Alzheimer's disease	3.62e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—INS—Alzheimer's disease	3.61e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—BCHE—Alzheimer's disease	3.6e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCR5—Alzheimer's disease	3.58e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—AKT1—Alzheimer's disease	3.55e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CALM1—Alzheimer's disease	3.55e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEP—Alzheimer's disease	3.53e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—APOE—Alzheimer's disease	3.53e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NGF—Alzheimer's disease	3.53e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CALM1—Alzheimer's disease	3.53e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—APOE—Alzheimer's disease	3.51e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ESR1—Alzheimer's disease	3.51e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HTR2A—Alzheimer's disease	3.51e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—Alzheimer's disease	3.5e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CAV1—Alzheimer's disease	3.5e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS3—Alzheimer's disease	3.49e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—Alzheimer's disease	3.48e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—AKT1—Alzheimer's disease	3.48e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—BCL2—Alzheimer's disease	3.48e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CAV1—Alzheimer's disease	3.48e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—F2—Alzheimer's disease	3.47e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PTGS2—Alzheimer's disease	3.46e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CALM1—Alzheimer's disease	3.44e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCR5—Alzheimer's disease	3.43e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEP—Alzheimer's disease	3.43e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—APOE—Alzheimer's disease	3.43e-06	1.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—Alzheimer's disease	3.4e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CAV1—Alzheimer's disease	3.4e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOTCH1—Alzheimer's disease	3.39e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	3.39e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—Alzheimer's disease	3.38e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—AKT1—Alzheimer's disease	3.38e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ESR1—Alzheimer's disease	3.37e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—AKT1—Alzheimer's disease	3.36e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HTR2A—Alzheimer's disease	3.36e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PTGS2—Alzheimer's disease	3.35e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—F2—Alzheimer's disease	3.33e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.33e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MAPK8—Alzheimer's disease	3.33e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—AKT1—Alzheimer's disease	3.31e-06	1.3e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ACHE—Alzheimer's disease	3.3e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	3.29e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CALM1—Alzheimer's disease	3.27e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ESR1—Alzheimer's disease	3.27e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.26e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEP—Alzheimer's disease	3.26e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—APOE—Alzheimer's disease	3.26e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INPP5D—Alzheimer's disease	3.26e-06	1.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—Alzheimer's disease	3.23e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—F2—Alzheimer's disease	3.23e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CAV1—Alzheimer's disease	3.23e-06	1.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—Alzheimer's disease	3.22e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.2e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MAPK8—Alzheimer's disease	3.2e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PTGS2—Alzheimer's disease	3.19e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—GSK3B—Alzheimer's disease	3.19e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—NOS3—Alzheimer's disease	3.17e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOTCH1—Alzheimer's disease	3.16e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CREB1—Alzheimer's disease	3.16e-06	1.24e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—INS—Alzheimer's disease	3.14e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—Alzheimer's disease	3.14e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—AKT1—Alzheimer's disease	3.13e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CALM1—Alzheimer's disease	3.13e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEP—Alzheimer's disease	3.12e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—APOE—Alzheimer's disease	3.12e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ESR1—Alzheimer's disease	3.11e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MAPK8—Alzheimer's disease	3.1e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—Alzheimer's disease	3.09e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL2—Alzheimer's disease	3.09e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CAV1—Alzheimer's disease	3.09e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ENO1—Alzheimer's disease	3.09e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS1—Alzheimer's disease	3.09e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—Alzheimer's disease	3.08e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—F2—Alzheimer's disease	3.08e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—GSK3B—Alzheimer's disease	3.06e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PPARG—Alzheimer's disease	3.06e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF1—Alzheimer's disease	3.04e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CREB1—Alzheimer's disease	3.04e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.03e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—INS—Alzheimer's disease	3.02e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.01e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—INS—Alzheimer's disease	3e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—AKT1—Alzheimer's disease	2.98e-06	1.17e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ESR1—Alzheimer's disease	2.98e-06	1.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL2—Alzheimer's disease	2.97e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—GSK3B—Alzheimer's disease	2.97e-06	1.16e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MAPK8—Alzheimer's disease	2.95e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CREB1—Alzheimer's disease	2.94e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—F2—Alzheimer's disease	2.94e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—INS—Alzheimer's disease	2.93e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1—Alzheimer's disease	2.92e-06	1.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTGS2—Alzheimer's disease	2.9e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL2—Alzheimer's disease	2.88e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOTCH1—Alzheimer's disease	2.88e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—Alzheimer's disease	2.87e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.87e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—AKT1—Alzheimer's disease	2.85e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	2.83e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1—Alzheimer's disease	2.83e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GSK3B—Alzheimer's disease	2.82e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	2.82e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MAPK8—Alzheimer's disease	2.82e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CREB1—Alzheimer's disease	2.8e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—INS—Alzheimer's disease	2.79e-06	1.09e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOS3—Alzheimer's disease	2.76e-06	1.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL2—Alzheimer's disease	2.74e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—AKT1—Alzheimer's disease	2.74e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.71e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GSK3B—Alzheimer's disease	2.7e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1—Alzheimer's disease	2.69e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CREB1—Alzheimer's disease	2.68e-06	1.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INS—Alzheimer's disease	2.67e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AKT1—Alzheimer's disease	2.65e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOS3—Alzheimer's disease	2.65e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NOS3—Alzheimer's disease	2.63e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.63e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL2—Alzheimer's disease	2.62e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.62e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.62e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—LPL—Alzheimer's disease	2.58e-06	1.01e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1—Alzheimer's disease	2.58e-06	1.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOS3—Alzheimer's disease	2.57e-06	1.01e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.51e-06	9.84e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—Alzheimer's disease	2.5e-06	9.79e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOS3—Alzheimer's disease	2.44e-06	9.57e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—Alzheimer's disease	2.42e-06	9.5e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.42e-06	9.47e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	2.41e-06	9.43e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—Alzheimer's disease	2.34e-06	9.16e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOS3—Alzheimer's disease	2.34e-06	9.15e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.34e-06	9.14e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	2.32e-06	9.1e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—Alzheimer's disease	2.31e-06	9.03e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.26e-06	8.87e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.25e-06	8.83e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—Alzheimer's disease	2.25e-06	8.8e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—Alzheimer's disease	2.23e-06	8.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—Alzheimer's disease	2.18e-06	8.54e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CALM1—Alzheimer's disease	2.17e-06	8.5e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—Alzheimer's disease	2.17e-06	8.48e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—APOE—Alzheimer's disease	2.16e-06	8.47e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MAPK8—Alzheimer's disease	2.15e-06	8.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CAV1—Alzheimer's disease	2.14e-06	8.39e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—Alzheimer's disease	2.12e-06	8.32e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—Alzheimer's disease	2.07e-06	8.12e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MAPK8—Alzheimer's disease	2.07e-06	8.09e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LPL—Alzheimer's disease	2.06e-06	8.07e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—Alzheimer's disease	2.06e-06	8.07e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—Alzheimer's disease	2.04e-06	7.99e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.03e-06	7.96e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.01e-06	7.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MAPK8—Alzheimer's disease	2e-06	7.85e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—Alzheimer's disease	2e-06	7.82e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—Alzheimer's disease	1.99e-06	7.77e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—Alzheimer's disease	1.98e-06	7.77e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—Alzheimer's disease	1.98e-06	7.75e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—Alzheimer's disease	1.96e-06	7.67e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—Alzheimer's disease	1.91e-06	7.47e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.91e-06	7.47e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.9e-06	7.45e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.9e-06	7.45e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.9e-06	7.45e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARG—Alzheimer's disease	1.88e-06	7.38e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—Alzheimer's disease	1.88e-06	7.38e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—Alzheimer's disease	1.88e-06	7.37e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.87e-06	7.31e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.86e-06	7.27e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—Alzheimer's disease	1.85e-06	7.24e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—Alzheimer's disease	1.85e-06	7.24e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—Alzheimer's disease	1.83e-06	7.15e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—Alzheimer's disease	1.83e-06	7.15e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MAPK8—Alzheimer's disease	1.82e-06	7.14e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	7.14e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—Alzheimer's disease	1.82e-06	7.11e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—Alzheimer's disease	1.8e-06	7.05e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.77e-06	6.93e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.76e-06	6.89e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—Alzheimer's disease	1.75e-06	6.86e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—Alzheimer's disease	1.74e-06	6.81e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—Alzheimer's disease	1.74e-06	6.8e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.73e-06	6.79e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—APOE—Alzheimer's disease	1.73e-06	6.77e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.71e-06	6.7e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—Alzheimer's disease	1.7e-06	6.65e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—Alzheimer's disease	1.69e-06	6.6e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—Alzheimer's disease	1.68e-06	6.59e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.67e-06	6.54e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—Alzheimer's disease	1.66e-06	6.51e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NOS3—Alzheimer's disease	1.62e-06	6.35e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.62e-06	6.34e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.62e-06	6.33e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—Alzheimer's disease	1.6e-06	6.28e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—Alzheimer's disease	1.55e-06	6.05e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.51e-06	5.89e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	5.87e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.48e-06	5.81e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—Alzheimer's disease	1.48e-06	5.78e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—Alzheimer's disease	1.44e-06	5.64e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—Alzheimer's disease	1.4e-06	5.47e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.4e-06	5.46e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.39e-06	5.44e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	5.38e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—Alzheimer's disease	1.33e-06	5.21e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—Alzheimer's disease	1.32e-06	5.17e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.29e-06	5.07e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—Alzheimer's disease	1.28e-06	5.01e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—Alzheimer's disease	1.27e-06	4.98e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.27e-06	4.97e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	4.96e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—Alzheimer's disease	1.22e-06	4.77e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—Alzheimer's disease	1.21e-06	4.74e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.18e-06	4.64e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—Alzheimer's disease	1.18e-06	4.62e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—Alzheimer's disease	1.16e-06	4.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.14e-06	4.48e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—Alzheimer's disease	1.12e-06	4.4e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	4.21e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.07e-06	4.18e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.06e-06	4.17e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.05e-06	4.13e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.27e-07	3.63e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—Alzheimer's disease	9.09e-07	3.56e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.98e-07	3.12e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—Alzheimer's disease	7.45e-07	2.92e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.29e-07	2.86e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.95e-07	2.33e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.67e-07	1.44e-06	CbGpPWpGaD
